A Relative Bioavailability and Food Effect Study of New Formulations
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the effect of 3 formulations on the relative
bioavailability of LY3009104. Participants will receive single dose of LY3009104 on 4
separate occasions with and without food. Safety evaluation and serial pharmacokinetic (PK)
samples will be collected during each treatment period. Approximately 5 to 7 days of washout
period between each treatment and a follow-up visit will occur approximately 5 to 7 days
after the last dose of study drug.